As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: December 14, 2016
by Canadian Institutes of Health Research:
Women today suffer from depression, stroke and dementia twice as much as men, and an astonishing 70 percent of new Alzheimer’s patients are women. The fact that these conditions affect more women suggests a role for biological sex differences that put women at higher risk for brain disorders and influence their response to treatment. Evidence also suggests that cultural and social factors as well as personal life experiences contribute to the higher rate of brain-related diseases in women.
Today, the Honourable Jane Philpott, Minister of Health, announced that one of Canada’s leading experts in the field of neuroscience, sex and gender will carry out a new research program that seeks to improve our understanding of why women are more affected by brain disorders. The program will also inform the development of new strategies to prevent, diagnose and treat diseases that affect the brain and promote brain health in women.
Dr. Gillian Einstein, a researcher and associate professor of psychology at the University of Toronto, will lead this research program as the recipient of The Wilfred and Joyce Posluns Chair in Women’s Brain Health and Aging. The Chair is an initiative of the late Wilfred Posluns’ Family Foundation and the Women’s Brain Health Initiative. It is supported through a partnership between the Foundation, the Canadian Institutes of Health Research, Alzheimer Society of Canada, and the Ontario Brain Institute.
Dr. Einstein was selected through a competitive process launched in March 2016. She will receive a grant of $1 million over five years to support her research program.
“Dementia, mental illness and other brain disorders are a major health challenge. They affect millions of Canadians and their families. I applaud Dr. Einstein for her commitment to improving women’s health and wish her every success as she pursues her ambitious and incredibly valuable research program.”
– Jane Philpott
Minister of Health
“It is an honour to be working with CIHR within their Dementia Research Strategy, the Ontario Brain Institute, the Women’s Brain Health Initiative, Alzheimer’s Society of Canada, and the Posluns Family Foundation to increase sex and gender awareness through research, mentorship, education, and knowledge translation initiatives. Together, we will enhance Canada’s position as an internationally-recognized focal point for significant advances in women’s brain health research.”
– Dr. Gillian Einstein
Wilfred and Joyce Posluns Chair in Women’s Brain Health and Aging
Department of Psychology & Dalla Lana School of Public Health, University of Toronto
“We’re thrilled with the appointment of Dr. Einstein as research chair and trust that the work she’ll be doing will help find the necessary answers for women to maintain their cognitive vitality throughout their lives.”
– Joyce Posluns
“Having someone of Dr. Einstein’s caliber build capacity in research that accounts for gender and sex on brain health and aging will greatly enhance women’s health. This type of research is important to better understand the unique risks between the two sexes, why differences exist, what the different outcomes are and whether they should be treated differently.”
– Lynn Posluns
Founder & President, Women’s Brain Health Initiative
“We are proud to be part of this important research initiative through CIHR’s Dementia Research Strategy. The work of Dr. Einstein and her team will complement the research being done by other dementia researchers in the country. It will contribute to our collective effort to find effective treatments for dementia, which affects women and women caregivers disproportionally, and make life better for all Canadians living with dementia and their families.”
– Dr. Yves Joanette
Scientific Director, CIHR Institute of Aging
Chair, World Dementia Council
“We’re excited to help advance research on women’s brain health through our Alzheimer Society Research Program. Dr. Einstein and her team will help fill a significant gap in dementia research. When we better understand how dementia affects women, we may be able to improve and develop more targeted treatments for every Canadian living with this disease.”
– Debbie Benczkowski
Chief Operating Officer, Alzheimer Society Canada
“Dr. Einstein is an exceptional researcher and we are very excited to support her in leading this important initiative. Her work will place much-needed focus on women’s brain health as well as contribute to ongoing initiatives investigating dementia, which disproportionately affects women.”
– Dr. Tom Mikkelsen
President and Scientific Director, Ontario Brain Institute
Approximately two-thirds of those diagnosed with Alzheimer’s disease (AD) are women. However, research into sex and gender differences in AD is astonishingly limited. Because the greatest risk factor for dementia is age, the discrepancy between...
Researchers at The University of Chicago have demonstrated that the type of bacteria living in the gut can influence the development of Alzheimer’s disease symptoms in mice. The study, which will be published May 16 in the Journal...
It is common for women to experience cognitive difficulties, sometimes referred to as “brain fog,” as they go through the menopause transition. They might be forgetful, or have trouble concentrating or thinking clearly. In one...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.